About Atila Biosystems
Atila Biosystems is a company based in Mountain View (United States) founded in 2009. Atila Biosystems offers products and services including Cancer Detection Assays, Blood Screening Assays, Respiratory Infection Assays, Bacterial Infections Assays, and NGS Library Preparation Assays. Atila Biosystems operates in a competitive market with competitors including Great Basin Scientific, Tangen Biosciences, HiberGene, RX Ventures and certus molecular diagnostics, among others.
- Headquarter Mountain View, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2 M (USD), Grant
Sep 05, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Atila Biosystems
Atila Biosystems offers a comprehensive portfolio of products and services, including Cancer Detection Assays, Blood Screening Assays, Respiratory Infection Assays, Bacterial Infections Assays, and NGS Library Preparation Assays.
Assays for detecting cancer-related nucleic acids accurately
Tests for screening blood samples for various conditions
Assays to identify respiratory viruses and bacteria
Tests for detecting bacterial pathogens in samples
Assays for preparing libraries in next-generation sequencing
Tests to identify drug resistance in pathogens
Assays for detecting infections in wound samples
Tests for sexually transmitted infections and related conditions
Assays to identify infections in the urethral tract
Tests for detecting fungal pathogens
People of Atila Biosystems
Unlock access to complete
Funding Insights of Atila Biosystems
Investors in Atila Biosystems
Atila Biosystems has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Atila Biosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Atila Biosystems
Investment portfolio details for Atila Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Atila Biosystems
Detailed financials for Atila Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atila Biosystems Comparisons
Peer comparison for Atila Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Atila Biosystems
Atila Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Great Basin Scientific, Tangen Biosciences, HiberGene, RX Ventures and certus molecular diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chip-based molecular diagnostics for infectious diseases are commercialized.
|
|
| Locked | Locked | Locked |
Developer of a molecular diagnostics platform
|
|
| Locked | Locked | Locked |
Develops and manufactures diagnostic tests for infectious diseases like meningitis.
|
|
| Locked | Locked | Locked |
Develops innovative technologies for amplification-based diagnosis of chronic health conditions.
|
|
| Locked | Locked | Locked |
Rapid tests for detecting specific microorganism genes are provided.
|
|
| Locked | Locked | Locked |
Genetic testing systems for Covid-19 detection are developed.
|
Detailed competitors of Atila Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atila Biosystems
Complete news archive for Atila Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atila Biosystems
Atila Biosystems was founded in 2009 and raised its 1st funding round 13 years after it was founded.
Atila Biosystems is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Youxiang Wang is the current CEO of Atila Biosystems.
Atila Biosystems was founded in 2009 and is based in Mountain View, United States. Operations focus on the biotechnology sector, where proprietary isothermal amplification technology is commercialized through high-multiplex, probe-based real-time fluorescent assays targeted at HPV detection. Complex samples are accommodated by the technology, which employs a single-step pipetting protocol. Compatibility is ensured with major qPCR instruments for all diagnostic kits.
Atila Biosystems's top competitors include Great Basin Scientific, Tangen Biosciences and certus molecular diagnostics.
Atila Biosystems offers Cancer Detection Assays, Blood Screening Assays, Respiratory Infection Assays, Bacterial Infections Assays, and 6 more products and services.
Atila Biosystems has 1 investor. Key investors include HHS.